These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9798655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy for aplastic anemia--review].
    Xu CY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
    [Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X, Zou Y, Wang S, Zhang L, Yang W, Zhang J, Liu F, Liu T, Chen X, Ruan M, Zhou J, Cai X, Qi B, Chang L, An W, Guo Y, Chen Y, Zhu X.
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
    Zheng Y, Liu Y, Chu Y.
    Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
    [Abstract] [Full Text] [Related]

  • 5. Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
    Doney K, Storb R, Appelbaum FR, Buckner CD, Sanders J, Singer J, Hansen JA.
    Br J Haematol; 1993 Sep; 85(1):182-4. PubMed ID: 8251389
    [Abstract] [Full Text] [Related]

  • 6. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
    Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A.
    Blood; 2000 Mar 15; 95(6):1931-4. PubMed ID: 10706857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A, Shibata A.
    Hematol Pathol; 1992 Mar 15; 6(3):143-53. PubMed ID: 1429342
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A, GITMO prospective randomized study.
    Haematologica; 2004 Sep 15; 89(9):1054-61. PubMed ID: 15377466
    [Abstract] [Full Text] [Related]

  • 10. Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia.
    Hord JD, Gay JC, Whitlock JA, Janco RL, Edwards JR, Greer JP, Lukens JN.
    J Pediatr Hematol Oncol; 1995 May 15; 17(2):140-4. PubMed ID: 7749763
    [Abstract] [Full Text] [Related]

  • 11. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q, Sha P, Chen H, Shen H, Qin L, Li Z, Wu T, Wang Z.
    Int J Hematol; 2018 Jan 15; 107(1):64-68. PubMed ID: 28900860
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G, Aktan M, Diz-Küçükkaya R, Yavuz S, Nalçaci M, Oztürk S, Palanduz S, Doğan O, Ağan M.
    Am J Hematol; 2007 Sep 15; 82(9):783-6. PubMed ID: 17506070
    [Abstract] [Full Text] [Related]

  • 13. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G.
    Blood; 1995 Mar 01; 85(5):1348-53. PubMed ID: 7532040
    [Abstract] [Full Text] [Related]

  • 14. [Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia].
    He G, Shao Z, Zhang Y, Liu H, Li K, Song L, Zheng Y, Chen G, He H, Zhao M, Shi J, Zhang H, Chu Y, Qian L, Yang T, Yang C.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Apr 01; 22(4):177-81. PubMed ID: 11877068
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M, Burdach S, Ebell W, Gadner H, Haas R, Harbott J, Janka-Schaub G, Klingebiel T, Kremens B, Niemeyer C, Rampf U, Reiter A, Ritter J, Schulz A, Walther U, Zeidler C, Bender-Götze C.
    Klin Padiatr; 1998 Apr 01; 210(4):173-9. PubMed ID: 9743949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.